SPHK1 and head and neck squamous cell carcinoma: Non-lipid SphK1 inhibitors such as SKI-I, SKI-II, and SK1-V have been used to decrease formation of S1P in mammary adenocarinoma xenograft models [140], but its effect in HNSCC has not been investigated.